Item 1.01 Entry Into A Material Definitive Agreement.
On
The Merger Agreement and the transactions contemplated thereby were unanimously
approved by the Board of Directors of Parent (the "Board") on
The Merger Agreement Merger Consideration
Pursuant to the Merger Agreement, the aggregate merger consideration payable to
the stockholders of the Company will be paid in a combination of stock and cash
consideration equal to
In connection with the Mergers, each share of the Company's capital stock (subject to limited exceptions) will be cancelled and automatically deemed for all purposes to represent the right to receive a portion of the Merger Consideration in accordance with the Company's organizational documents.
Each vested option of the Company ("Company Option") will be cancelled and converted into the right to receive a portion of the Merger Consideration in accordance with the terms thereof, net of the exercise price of such vested Company Option, in each case, without interest. If the exercise price payable in respect of a share of Company common stock under a vested Company Option exceeds the applicable portion of the Merger Consideration payable in respect of such share of Company common stock, such vested Company Option shall be cancelled for no consideration. Each unvested Company Option will be converted into an option to purchase shares of Parent Class A common stock (and shall be equitably adjusted for the terms of the transactions) and will continue to be governed by substantially the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Company Option.
Each warrant to purchase shares of capital stock of the Company ("Company Warrants") will be cancelled in exchange for the right to receive a portion of the Merger Consideration, in accordance with the terms thereof, net of the exercise price of such Company Warrant, in each case, without interest. If the exercise price payable in respect of a share of Company common stock under a Company Warrant exceeds the applicable portion of the Merger Consideration payable in respect of such share of Company common stock, such Company Warrant shall be automatically terminated for no consideration.
1
Representations, Warranties and Covenants
The parties to the Merger Agreement have made representations, warranties and covenants that are customary for transactions of this nature. The representations and warranties contained in the Merger Agreement will not survive the closing of the transaction, other than in the event of actual fraud.
The Merger Agreement contains additional covenants of the parties, including,
among others, covenants providing for (a) the parties to conduct their
respective businesses in the ordinary course through the consummation of the
Mergers, (b) Parent and the Company (x) being prohibited from soliciting or
negotiating with third parties regarding alternative transactions and agreeing
to certain related restrictions and (y) to cease discussions regarding
alternative transactions, (c) Parent and the Company to jointly prepare (and for
Parent to file with the
Conditions to Consummation of the Mergers
The consummation of the transactions contemplated by the Merger Agreement is
subject to customary closing conditions for special purpose acquisition
companies, including, among others: (a) approval by Parent's stockholders and
the Company's stockholders, (b) Parent having at least
Item 3.02 Unregistered Sales of
The disclosure set forth above under the heading "Private Placement Subscription Agreements" in Item 1.01 of this Current Report on Form 8-K (this "Current Report") is incorporated by reference into this Item 3.02. The shares of Parent Class A common stock to be issued in the Private Placement in connection with the closing will not be registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.
Item 7.01 Regulation FD Disclosure.
On
Attached as Exhibit 99.2 and incorporated by reference herein is the investor presentation dated July, 2020 that will be used by Parent with respect to the transactions contemplated by the Merger Agreement.
4
Attached as Exhibit 99.3 and incorporated by reference herein is an investor
presentation that will be used by Parent during a webcast for investors and
analysts on
The information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of Parent under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Current Report will not be deemed an admission as to the materiality of any of the information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2.
Company Risk Factors
The Company and Parent caution you that the Company's business is subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company and Parent, including the following: the Company operates in a competitive industry; the level of demand for and market utilization of its solutions are subject to a high degree of uncertainty; the Company has a history of losses, and anticipates that it will continue to incur losses in the future; the Company may never achieve or sustain profitability; the Company's business, financial condition and results of operations may be adversely affected by the COVID-19 pandemic or other similar epidemics or adverse public health developments, including government responses to such events; developments affecting spending by the healthcare industry could adversely affect the Company's business; the Company's success depends on existing customers' continuing or renewing their contracts; the Company's telemedicine business and growth strategy depends on its ability to maintain and expand a network of qualified physicians and other provider specialists; the Company's telemedicine business is dependent on its relationships with affiliated professional entities, which it does not own, to provide physician services, and its business would be adversely affected if those relationships were disrupted; the Company depends upon third-party providers for certain technologies and equipment, and the loss of any of these providers, or their inability to meet the Company's needs could adversely affect its business; the Company's business could be harmed if it is unable to develop and release new solutions, or successful enhancements, new features and modifications to its existing solutions or if its solutions fail to operate as expected, including as a result of internet service interruptions; the Company may become subject to claims for medical liability, misuse and disclosure of personally identifiable information and data breaches; and government regulation of healthcare creates risks and challenges with respect to our compliance efforts and the Company's business strategies.
The Company and Parent urge you to carefully consider these and other risks, including as set forth below under "Forward-Looking Statements", that are inherent in an investment in Parent in connection with the business combination or the Company. If we cannot address any of the these risks and uncertainties effectively, or any other risks and difficulties that may arise in the future, the Company's business, financial condition or results of operations could be materially and adversely affected. The foregoing risks are not the only ones faced by the Company. Additional risks that the Company or Parent currently do not know about or that they currently believe to be immaterial could also have a material adverse effect on the Company's business, financial condition or results of operations. Investors are encouraged to review the investor presentations attached to this Current Report.
Forward-Looking Statements
This Current Report may contain a number of "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning Parent's or the Company's possible or assumed future results of operations, business strategies, debt levels, competitive position, industry environment, potential growth opportunities and the effects of regulation, including whether this transaction will generate returns for stockholders. These forward-looking statements are based on Parent's or the Company's management's current expectations, estimates, projections and beliefs, as well as a number of assumptions concerning future events. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
5
These forward-looking statements are not guarantees of future performance,
conditions or results, and involve a number of known and unknown risks,
uncertainties, assumptions and other important factors, many of which are
outside Parent's or the Company's management's control, that could cause actual
results to differ materially from the results discussed in the forward-looking
statements. These risks, uncertainties, assumptions and other important factors
include, but are not limited to: (a) the occurrence of any event, change or
other circumstances that could give rise to the termination of the Merger
Agreement and the proposed transactions contemplated thereby, (b) the inability
to complete the transactions contemplated by the Merger Agreement due to the
failure to obtain approval of the stockholders of Parent or other conditions to
closing in the Merger Agreement, (c) the ability to meet Nasdaq's listing
standards following the consummation of the transactions contemplated by the
Merger Agreement, (d) the inability to complete the Private Placement, (e) the
risk that the proposed transactions disrupt current plans and operations of the
Company or its subsidiaries as a result of the announcement and consummation of
the transactions described herein, (f) the ability to recognize the anticipated
benefits of the proposed transactions, which may be affected by, among other
things, competition, the ability of the combined company to grow and manage
growth profitably, maintain relationships with healthcare organizations and
network of qualified physicians and other provider specialists and retain its
management and key employees, (g) costs related to the proposed transactions,
(h) changes in applicable laws or regulations, (i) the possibility that the
Company may be adversely affected by other economic, business, and/or
competitive factors and (j) other risks and uncertainties indicated in the
preliminary or definitive joint proxy statement/consent solicitation
statement/prospectus that forms a part of the Registration Statement, including
those under "Risk Factors" therein, and other documents filed or to be filed
with the
Forward-looking statements included in this Current Report speak only as of the
date of this Current Report. Except as required by law, neither Parent nor the
Company undertakes any obligation to update or revise its forward-looking
statements to reflect events or circumstances after the date of this release.
Additional risks and uncertainties are identified and discussed in Parent's
reports filed with the
Disclaimer
This Current Report is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities pursuant to the proposed transactions or otherwise, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.
INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE PROPOSED TRANSACTIONS OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
Additional Information About the Transactions
Parent intends to file the Registration Statement with the
Item 9.01 Financial Statements and Exhibits.
(d) List of Exhibits.
The Exhibit Index is incorporated by reference herein.
7
© Edgar Online, source